3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
8
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Interventions
Gene Expression Profiling
11
Surveys and Questionnaires
9
Polymerase Chain Reaction
9
Immunohistochemistry
9
Amplified Fragment Length Polymorphism Analysis
9
Flow Cytometry
8
Psychiatric Rehabilitation
7
Microarray Analysis
6
Rituximab
5
Interviews as Topic
4
Cytogenetic Analysis
4
Blood Specimen Collection
4
Biopsy
4
Therapeutics
3
Immunologic Techniques
3
Gene Rearrangement
3
Drug Therapy
3
Doxorubicin
3
Data Collection
3
Cyclophosphamide
3
plerixafor
2
Vincristine
2
Prednisone
2
Positron-Emission Tomography
2
Phlebotomy
2
Pharmacogenomic Testing
2
Observation
2
Neuropsychological Tests
2
Mental Status and Dementia Tests
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lymphoma
×
duvelisib
×
Clear all
NCT04342117
2021-03-17
REAL
SecuraBio
Terminated
2 enrolled